SHL Telemedicine Ltd.
SHL Telemedicine Ltd. (SIX: SHLTN) is trading at CHF 1.05, about ₹121 at today's CHF/INR rate, as of 30 Sep 2026, 11:31 AM ET, down 1.87% today. Indian residents can buy SHL Telemedicine from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CHF 0.99
Today's high
CHF 1.07
52 week low
CHF 0.61
52 week high
CHF 1.49
SHLTN opened at CHF 1.01, closed previously at CHF 1.07, and has traded between CHF 0.61 and CHF 1.49 over the past 52 weeks.
About
Established in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine Ltd. is a global provider specializing in the development and distribution of individual remote healthcare solutions across Israel, Europe, and other international markets. The company's extensive product line includes a variety of advanced electrocardiogram (ECG) devices designed for personal use: Smartheart, a mobile 12-lead ECG capable of identifying heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter; Cardio'B, a portable 12-lead ECG unit; and the Cardio Beeper 12/12, a handheld device that transmits full ECG readings to a monitoring center. Beyond cardiac monitoring, SHL offers a suite of other remote diagnostic tools, such as a central communication module for relaying medical data from various devices to its telemedicine centers, TeleWeight for trans-telephonic weight tracking, TelePress for remote blood pressure measurements, TeleBreather for assessing lung function, and the TelePulse Oximeter for measuring blood oxygen saturation and pulse rate. These telemedicine services and devices are delivered to subscribers via both telephonic and internet communication channels. The company caters to a diverse range of clients, including individual patients, health insurance providers, hospitals, clinics, medical practitioners, and other healthcare organizations. SHL Telemedicine is also engaged in key collaborative research efforts. It partners with the Mayo Clinic to evaluate the efficacy of its FDA-approved SmartHeart in reducing emergency department visits, re-hospitalizations, and major adverse cardiovascular events in post-heart attack patients over a 90-day period. Additionally, the company is working with the Hebrew University of Jerusalem and the Hadassah Medical Center to create an artificial intelligence tool designed to predict future life-threatening cardiac incidents based on 12-Lead ECG monitoring.
Key statistics
Avg. volume
14.34K
Market cap
CHF 38.91M
P/E Ratio
-1.20
Price-to-sales ratio
0.59
Enterprise value
$19.73M
Free cash flow yield
-10.91%
Debt-to-equity ratio
0.41
Return on equity
-36.83%
ROIC
-7.90%
Beta
-0.17
Dividend yield
0.00%
Last dividend
CHF 0.00
Financial overview
Revenue
$61.49M
Earnings per share
-$0.76
Free cash flow
-$3.48M
Net profit margin
-49.48%
Gross margin
45.43%
EBITDA
$3.28M
Revenue growth
8.29%
Similar securities
This is not an investment recommendation
How to buy SHL Telemedicine from India
Indian residents can buy SHL Telemedicine shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CHF.
Search for SHL Telemedicine and place an order
Find SHL Telemedicine by name or by its ticker, SHLTN, and choose an order type. SHL Telemedicine trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your SHL Telemedicine position in CHF and INR. SHL Telemedicine pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in SHL Telemedicine from India
Trading and taxes when buying SHL Telemedicine from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneSHL Telemedicine does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy SHL Telemedicine stock?
Yes. SHL Telemedicine (SHLTN) has been listed on the SIX Swiss Exchange since 2000, in the Medical - Healthcare Information Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CHF. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one SHL Telemedicine share cost in rupees?
One SHL Telemedicine share is CHF 1.05 — about ₹121 at a CHF/INR rate of 115.18 on 29 Sep 2026. Both the SHL Telemedicine price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying SHL Telemedicine from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on SHL Telemedicine shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CHF/INR rate on the purchase and the sale date, so the rupee move counts alongside the SHL Telemedicine price. Paasa issues a capital-gains statement for your return.
Does SHL Telemedicine pay a dividend?
No. SHL Telemedicine does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade SHL Telemedicine from India?
The SIX Swiss Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Switzerland is on standard time. Orders can only execute during that window.
Is SHL Telemedicine a Switzerland company, and does that change how it is taxed?
SHL Telemedicine trades on the SIX Swiss Exchange in CHF, but the company is domiciled in Israel. SHL Telemedicine trades as an ordinary share listed directly in Switzerland, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare SHL Telemedicine shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your SHL Telemedicine holding, its cost and its closing value.
How do I sell SHL Telemedicine and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in CHF in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on SHL Telemedicine?
Yes. SHL Telemedicine is priced in CHF, so your rupee outcome combines the CHF move with the CHF/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.